Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
SUSPENDED
NCT05866679
PHASE1
Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging
Sponsor: M.D. Anderson Cancer Center
View on ClinicalTrials.gov
Summary
To learn if an MRSI can be performed on a 3T scanner using an investigational contrast drug called hyperpolarized 13-C pyruvate. 3T refers to the "strength" of the MRI machine.
Key Details
Gender
FEMALE
Age Range
18 Months - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-04-12
Completion Date
2028-08-31
Last Updated
2026-04-15
Healthy Volunteers
No
Conditions
Interventions
DRUG
Hyperpolarized 13-C-pyruvate
Given by PO
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States